Juno Therapeutics' Series A - II Round

Juno Therapeutics raised a round of funding on January 14, 2014.

Juno Therapeutics (NASDAQ: JUNO) is a clinical-stage company that brings together three of the world's leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cance…

Articles about Juno Therapeutics' Series A - II Round: